共 61 条
- [1] do Carmo Costa M., Paulson H.L., New hope for therapy in neurodegenerative diseases, Cell Res., 23, 10, pp. 1159-1160, (2013)
- [2] Ciechanover A., Kwon Y.T., Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies, Exp. Mol. Med., 47, 3, pp. e147-e, (2015)
- [3] Atkin G., Paulson H., Ubiquitin pathways in neurodegenerative disease, Front. Mol. Neurosci., 7, (2014)
- [4] Nijholt A.T., D., Et al., Removing protein aggregates: the role of proteolysis in neurodegeneration, Curr. Med. Chem., 18, 16, pp. 2459-2476, (2011)
- [5] Martin I., Dawson V.L., Dawson T.M., Recent advances in the genetics of Parkinson's disease, Annu. Rev. Genomics Hum. Genet., 12, pp. 301-325, (2011)
- [6] Macleod A.D., Grieve J.K., Counsell C.E., A systematic review of loss of independence in Parkinson's disease, J. Neurol., 263, pp. 1-10, (2016)
- [7] Han S., Et al., Prevalence and incidence of Parkinson's disease and drug-induced parkinsonism in Korea, BMC Public Health, 19, pp. 1-9, (2019)
- [8] Shulman J.M., De Jager P.L., Feany M.B., Parkinson's disease: genetics and pathogenesis, Annu. Rev. Pathol., 6, pp. 193-222, (2011)
- [9] Devine M.J., Et al., Parkinson's disease and α‐synuclein expression, Mov. Disord., 26, 12, pp. 2160-2168, (2011)
- [10] Tan E., Et al., Variability and validity of polymorphism association studies in Parkinson's disease, Neurology, 55, 4, pp. 533-538, (2000)